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The control of glycolysis in contracting muscle is not fully
understood. The aim of the present study was to examine whether
activation of glycolysis is mediated by factors related to the
energy state or by a direct effect of Ca2+ on the regulating
enzymes. Extensor digitorum longus muscles from rat were
isolated, treated with cyanide to inhibit aerobic ATP production
and stimulated (0.2 s trains every 4 s) until force was reduced to
70% of initial force (control muscle, referred to as Con). Muscles
treated with BTS (N-benzyl-p-toluene sulfonamide), an inhibitor
of cross-bridge cycling without affecting Ca2+ transients, were
stimulated for an equal time period as Con. Energy utilization by
the contractile apparatus (estimated from the observed relation
between ATP utilization and force–time integral) was 60% of
total. In BTS, the force–time integral and ATP utilization were
only 38 and 58% of those in Con respectively. Glycolytic rate in
BTS was only 51% of that in Con but the relative contribution
of ATP derived from PCr (phosphocreatine) and glycolysis and
the relation between muscle contents of PCr and Lac (lactate)
were not different. Prolonged cyanide incubation of quiescent
muscle (low Ca2+) did not change the relation between PCr and
Lac. The reduced glycolytic rate in BTS despite maintained Ca2+
transients, and the unchanged PCr/Lac relation in the absence of
Ca2+ transients, demonstrates that Ca2+ is not the main trigger
of glycogenolysis. Instead the preserved relative contribution of
energy delivered from PCr and glycolysis during both conditions
suggests that the glycolytic rate is controlled by factors related to
energy state.
Key words: energy turnover, glycogenolysis, glycolysis,
N-benzyl-p-toluene sulfonamide, phosphocreatine, skeletal
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INTRODUCTION
Skeletal-muscle energy turnover can increase more than 100-fold
during high-intensity exercise. Thus the muscle faces intricate
problems related to fuel homoeostasis and metabolic regulation.
The precision in adjusting the rate of ATP generating processes
to the energy requirements is remarkable and is achieved by both
feedforward and feedback control [1]. Carbohydrate utilization
is of major importance for ATP regeneration during exercise and
therefore a precise control of the rate of glycolysis is required.
The rate of glycogen utilization is in the order of 3–4 mmol
glycosyl units · kg− 1 · min− 1 at 100% ˙V O2max, and can increase to
30–50 mmol glycosyl units kg− 1 min− 1 during maximal dyna-
mic or static contractions [2]. Despite its key importance
in metabolism and despite intensive research, the control of
glycolysis during exercise is not fully understood.
The conventional view of glycogenolytic/glycolytic control
in muscle is that GP (glycogen phosphorylase) and PFK
(phosphofructokinase) are the key rate-limiting steps. GP is
activated by increases in the concentration of allosteric modulators
[AMP and IMP (inosine mono-phosphate)] and substrate Pi and by
phosphorylation of the less active form (GPb) into the more active
form (GPa). Phosphorylation of GPb is catalysed by phos-
phorylase kinase, which in turn is activated by the cAMP cascade
and/or Ca2+. PFK activity is regulated by the concentrations
of adenine nucleotides, Pi, citrate and fructose bisphosphates.
Furthermore, Ca2+ and calmodulin have been shown to increase
the activity of PFK and to act synergistically with increased levels
of AMP and ADP [3]. However, the allosteric effect of Ca2+
and calmodulin were measured in vitro with diluted enzyme and
the role of Ca2+ in activating PFK needs to be established at
physiological enzyme concentrations or alternatively confirmed
in whole muscle.
Glycolytic flux, which is intimately related to glycogenolytic
flux, increases severalfold during muscle contraction in close
relation to the frequency of muscle activation but is immediately
shut down when the contraction terminates even during anaerobic
conditions [4–6]. This suggests that the control of glycolysis is
exerted by some factor(s) intimately related to the contraction
process. The control of glycolysis in contracting muscle has been
studied extensively and two main theories have emerged. One
theory is that the rate of glycolysis is under feedback control by the
energy demand through increased concentrations of the products
of ATP hydrolysis (ADP, AMP and Pi). Another possibility is that
glycolysis is under feedforward control by cytosolic Ca2+, which
changes rapidly in concert with contractile activity [4,7,8]. The
relative importance of these two factors (Ca2+ or energy status) in
the regulation of glycolysis has been disputed. Conley et al. [7,8]
used 31P MRS (magnetic resonance spectroscopy) to measure
the kinetics of PCr (phosphocreatine), Pi, ATP, sugar phosphates
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and pH in contracting human muscle. Glycolytic rate, calculated
from measured parameters, was similar during ischaemic and
non-ischaemic conditions and thus was independent of metabolic
feedback by Pi, ADP and AMP. The hypothesis that glycolysis
is controlled by products of ATP hydrolysis was therefore
questioned [7]. The dependence of glycolytic rate on muscle
stimulation frequency [8] and the independence of glycolytic
rate on the feedback control mechanism are consistent with the
view that glycolysis is controlled solely by Ca2+ and not by the
cellular energy status. However, there are limitations and pitfalls
with estimating the glycolytic rate with the MRS method. It has
been pointed out that the MRS method can result in incorrect
calculation of glycolytic rate due to overestimation of changes in
pHm (muscle pH) in a mixed fibre muscle and an unjustified
assumption that Lac (lactate) accumulation has a lag phase
during the initial period of contraction [9]. Therefore the role of
Ca2+ in the control of the glycolytic rate needs to be reinvestigated
with alternative experimental techniques.
Several textbooks convey the message that increases in Ca2+ is
the major factor in the control of glycogenolysis during exercise
[10–13], whereas others conclude that metabolic feedback by
energy status is an important part of the control [14]. Control
of glycolysis in contracting muscle is a fundamental issue of
great importance for our understanding of muscle energetics. It is
therefore important to clarify this point by further experimental
work.
A possible experimental approach to investigate this issue
would be to dissociate the normal Ca2+ transients in a contracting
muscle from energy turnover. A potential tool to maintain
normal Ca2+ transients during excitation while decreasing ATP
turnover is the cross-bridge cycle blocker, BTS (N-benzyl-p-
toluene sulfonamide). More specifically, BTS suppresses force
production by inhibiting the release of Pi together with a decrease
in the apparent affinity for S1*ADP*Pi and S1*ADP (S1 is
subfragment 1 of myosin) for actin, and BTS appears to act
specifically on the myosin heavy-chain type II isoform [15,16].
Furthermore, BTS does not alter the Ca2+ transients of electrically
stimulated single fibres from rabbit [15] or mouse [17,18], it
does not impair normal muscle excitability [19], and it does not
affect the SR (sarcoplasmic reticulum) Ca2+ pump ATP utilization
[20]. The ability to inhibit cross-bridge cycling with BTS, thereby
decreasing ATP turnover in the muscle cell, without altering any
of the upstream processes in the E–C (excitation–contraction)
coupling such as SR Ca2+ transients, makes BTS an excellent
tool for the study of the role of Ca2+ and/or metabolites in the
activation of skeletal-muscle glycogenolysis.
In previous studies, it was reported that there is a strong
correlation between muscle Lac accumulation and PCr levels
during both static and dynamic contractions [21]. The PCr/Lac
ratio links glycolytic flux and the creatine kinase reaction and
is therefore an ideal tool to distinguish abnormalities in energy
metabolism. Contracting muscle incubated with BTS has a low
energy turnover, whereas Ca2+ transients are maintained similar
to those in muscles not treated with BTS. If the hypothesis
that Ca2+ is an important trigger of glycolysis is correct, one
would expect that the relative ATP provision by glycolysis would
increase in BTS-treated muscles. Another approach is to inhibit
aerobic ATP formation in quiescent muscle by cyanide and thus
to increase the rate of anaerobic ATP formation (PCr utilization
and glycolysis) without increases in Ca2+. If the hypothesis that
Ca2+ is an important trigger of glycolysis is correct, one would,
due to the absence of Ca2+ transients, expect that the relation
would change towards a lower Lac and a higher PCr utilization.
Conversely, if glycolysis is controlled by energy status one would
expect that the relation between PCr and Lac would be similar to
that in stimulated control muscles both in muscles treated with
BTS and during prolonged cyanide treatment.
It is generally accepted that actomyosin ATPase accounts for
most of the ATP consumed during muscle contractions at maximal
or near-maximal force, i.e. 50–80% of total energy consumption
[18,22–30]. BTS selectively inhibits the cross-bridge cycling,
while muscle ion pumping remains unchanged, thereby enabling
precise estimation of the relative energy utilization by the con-
tractile apparatus. Using BTS, the cross-bridge ATP requirement
during isometric contractions has been reported to be 20–30%
of overall ATP consumption [31], which advocates for further
estimates of the ATP utilization by the relative cross-bridge.
The aim of the present study was, therefore, to test the hypo-
thesis that the glycolytic and glycogenolytic rates are controlled
by cellular energy status and not by a direct effect of Ca2+ on the
regulating enzymes. We have specifically investigated the effect
of modified energy turnover, while maintaining unchanged Ca2+
transients by using the cross-bridge cycling blocker BTS and
the effect of blunted Ca2+ transients by incubating muscles with
cyanide for a prolonged period. A second purpose of the study was
to determine the relative ATP turnover by the cross-bridge cycling
during intermittent static contractions. Our findings demonstrate
that the glycogenolytic rate is controlled by factors related to
energy state, but not directly by increases in Ca2+ and that cross-
bridge cycling accounts for 60% of skeletal-muscle total energy
turnover during intermittent static contractions.
EXPERIMENTAL
Animals, preparation and incubation of muscles
All handling and use of animals complied with Danish animal
welfare regulations. Experiments were performed using 12-week-
old Wistar rats, weighing approx. 250 g, which were kept in a
thermostatically maintained environment at 21 ◦C with a 12 h
dark/12 h dark cycle and fed ad libitum. The animals were
killed by cervical dislocation, followed by decapitation. Intact
EDL (extensor digitorum longus) muscles were prepared and
incubated in standard KR buffer (Krebs–Ringer bicarbonate
buffer) containing the following (in mM): 122.1 NaCl, 25.1
NaHCO3, 2.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1.3 CaCl2 and 5.0 D-
glucose (pH 7.4). All incubations were performed at 25 ◦C under
continuous gassing with a mixture of 95% O2 and 5% CO2.
Force measurements
Muscles were mounted for isometric contractions in thermos-
tatically maintained chambers containing standard KR buffer and
adjusted to optimal length for force production. After a 30 min
rest, muscle contractility was tested once, using a short 0.5 s
train of 60 Hz, 0.2 ms, 12 V supramaximal pulses (initial F).
Muscles were then incubated in a standard KR buffer for 90 min
or with 50 μM BTS for a matching time. As BTS was dissolved
in DMSO, an equivalent amount of DMSO (0.05%) was added
to control muscles. For the final 5 min of the 90 min incubation,
standard KR buffer was replaced with glucose-free KR buffer
containing 2 mM NaCN, which prevented glucose transport into
the muscle cell and mitochondrial oxygen utilization respectively.
Muscles then underwent fatiguing stimulation using 0.2 s trains of
60 Hz, 0.2 ms, 12 V supramaximal pulses every 4 s until force was
reduced to 70% of initial force response [Con (control muscles)].
BTS-treated muscles were stimulated for an equal time period as
Con muscle. Resting values were obtained from the corresponding
contralateral muscles (Con rest and BTS rest), which were treated
as above, i.e. incubated with or without BTS for 90 min and
2 mM NaCN for the last 5 min plus the corresponding time of
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the stimulation protocol (88 s). Furthermore, a series of muscles
underwent fatiguing stimulation until force was reduced to 85%
of initial force response (Con1/2, n = 4). In order to elucidate the
effect of an increased energy turnover on muscle metabolite levels,
during resting [Ca2+] (Ca2+ concentration), an additional series of
resting muscles (n = 12) was incubated with 2 mM cyanide for
10 min, at a higher temperature (30 ◦C).
Force was measured using force displacement transducers and
recorded with a chart recorder and digitally on a computer. Results
are expressed as a percentage of initial F.
Immediately after fatiguing stimulation, the chamber was
lowered, leaving the muscle suspended in air, before the muscles
were rapidly detached and frozen in liquid N2 while stirring
and stored at –80 ◦C until assessment of metabolites. This entire
procedure was completed in less than 5 s. A sample of the buffer
(1 ml from a total of 7 ml) was taken for determination of Lac
that has been released from the muscle into the solution during
the fatiguing stimulation.
Metabolite measurements
Muscles were frozen and later freeze-dried, dissected free of
non-muscle tissue, powdered and extracted with HClO4 as
previously described [32]. Neutralized extracts were analysed
for Lac, ATP, ADP, AMP, PCr, Cr (creatine), glucose, G-1-P
(glucose 1-phosphate), G-6-P (glucose 6-phosphate), F-6-P (fru-
ctose 6-phosphate) and Pyr (pyruvate), as previously described
[32]. In order to adjust for variability in solid non-muscle
constituents and weighing variability, all values are normalized
by dividing by the total amount of creatine (PCr + Cr) and
multiplied by the mean of total creatine for the whole material
[145.1 mmol · kg− 1 dm (dry muscle)]. In addition the buffer
solution was analysed for Lac in the same way as the muscle
extract in order to estimate the total muscle Lac production.
Muscle glycogen was analysed from a separate portion of the
freeze-dried muscle by the method of Lowry and Passonneau [33].
The metabolic changes after stimulation of Con and BTS muscles
were calculated from the difference from the non-stimulated
contralateral muscles in each animal.
Calculations
GI (glycolytic intermediates) were calculated as the sum of glu-
cose, G-6-P, G-1-P and F-6-P. Lac was determined from the sum
of muscle Lac and Lac released to the buffer. ATP utilization
was estimated from substrate phosphorylation as: –PCr–
(2ATP–ADP) + 1.5Lac + 1.5Pyr, where  refers to the
difference between metabolite concentration in the stimulated
muscle and the contralateral resting muscle. Glycolytic flux was
calculated from (Lac +Pyr)/2, and glycogenolytic flux was
calculated from the sum of glycolytic flux and accumulated GI.
pHm was determined using the equation: pHm = 7.06–0.00532
(Lac + pyruvate) [34]. Muscle-free ADP and free AMP are the
metabolically active forms, and have been estimated from the
creatine kinase and adenylate kinase equilibrium [35].
The metabolic rates are given per total time of stimulation,
88 s (Con) and 90 s (BTS). The force–time integral, calculated as
the area below the force tracings, was used as an estimate of the
isometric ‘work’.
Chemicals
All chemicals were of analytical grade and, unless otherwise
stated, were obtained from Sigma–Aldrich, with BTS obtained
from Toronto Research Chemicals.
Figure 1 Effect of BTS on force production during fatiguing stimulation
Muscles were stimulated using supramaximal 60 Hz, 0.2 s pulses every 4 s, in the absence
(controls,) or presence (H17009) of BTS. BTS muscles were incubated in 50 μM BTS for 90 min
prior to fatiguing stimulation. Control muscles were stimulated until force was reduced to 70 %
of initial force. BTS muscles were stimulated for the time corresponding to the average time of
stimulation for control muscles. Data points correspond to means +− S.E.M.; n = 5–8 and 8 for
control and BTS muscles respectively and are normalized to the initial force produced 90 min
prior to fatiguing stimulation. *Statistically significant difference from initial force.
Statistics
Statistical comparisons were made using either a Student’s t test
or one-way ANOVA, where appropriate. Significant differences
between means were located using the Bonferroni post hoc test.
Statistical significance was accepted at P < 0.05. All values are
given as means +− S.E.M.
RESULTS
Force production and force–time integrals during fatiguing
isometric stimulation
Summarized data of force production during fatiguing stimulation
are shown in Figure 1. Muscles were stimulated intermittently at
60 Hz until force was reduced to 70% (Con) of initial force
response, which corresponded to 88.4 +− 8.6 s (Figure 1). Initial
force averaged 0.81 +− 0.05 N for Con, which corresponds to
83% of maximum tetanic force (100 Hz). The initial force, in
stimulated BTS muscle, was 17 +− 2.1% of that in Con and did
not significantly change during the 90 s stimulation (Figure 1).
The isometric ‘work’ (force–time integral) in BTS muscles
was only 38% of that in Con muscles (1.25 +− 0.00 N s and
3.30 +− 0.24 N s respectively). Thus BTS muscles had a much
lower force production and isometric ‘work’ than Con. There was
no difference in force–time integrals between Con1/2 muscles,
stimulated until the force was reduced to 85% of the initial force
response (41.6 +− 3.4 s), and BTS-treated muscles.
Muscle metabolites
Muscle metabolites measured in stimulated muscles and in the
respective contralateral non-stimulated muscles incubated for the
same time and under the same conditions are presented in Tables 1
and 2. There was no difference between conditions in the metabo-
lite contents of non-stimulated muscles. Thus, in agreement with
previous reports, BTS did not alter resting metabolite levels [36].
Muscle contents of ATP, PCr and Lac are in the same order
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Table 1 Content of ATP, ADP, AMP, PCr and Cr in stimulated and non-stimulated muscles
The values shown are means +− S.E.M. and are given as mmol · kg− 1 dw, except for ADPfree and AMPfree, which are given as μmol · kg− 1 dw; n = 8 for all conditions. ADPfree and ADPfree are the
calculated concentrations of free ADP and AMP respectively.
Con non-stimulated Con stimulated BTS non-stimulated BTS stimulated
ATP 29.6 +− 0.2 29.4 +− 0.4 28.6 +− 0.4 28.4 +− 0.4
ADP 3.3 +− 0.1 4.0 +− 0.1* 3.3 +− 0.1 4.0 +− 0.1*
AMP 0.1 +− 0.02 0.1 +− 0.01 0.1 +− 0.01 0.2 +− 0.03
TAN 33.0 +− 0.2 33.6 +− 0.4 32.0 +− 0.4 32.5 +− 0.4
ADPfree 79.8 +− 6.2 554.4 +− 24.2* 85.5 +− 2.8 272.5 +− 12.1*†
AMPfree 0.2 +− 0.04 10.1 +− 0.9* 0.3 +− 0.02 2.5 +− 0.2*†
PCr 103.3 +− 2.5 27.4 +− 1.0* 99.9 +− 1.3 52.2 +− 1.1*†
Cr 41.8 +− 2.5 117.7 +− 1.0* 45.2 +− 1.3 92.9 +− 1.1*†
PCr+Cr 143.7 +− 3.1 141.5 +− 2.2 146.7 +− 4.2 142.7 +− 3.0
*Significantly different from the corresponding resting value.
†Significantly different from Con.
Table 2 Muscle content of glycogen and glycolytic intermediates at rest and after stimulation
Values are means +− S.E.M. and metabolites are expressed as mmol · kg− 1 dw; n = 8 for all conditions. Glycogenolytic flux was calculated from GI + 0.5(Lac +Pyr), where GI is the sum of
glucose, G-6-P, G-1-P and F-6-P and Lac is the sum of Lac accumulated in the muscle and Lac released to the buffer.
Con non-stimulated Con stimulated BTS non-stimulated BTS stimulated
Glycogen 120.8 +− 3.6 94.5 +− 3.5* 111.2 +− 4.3 97.6 +− 4.6*
GI 1.8 +− 0.1 4.2 +− 0.6* 2.4 +− 0.2 3.6 +− 0.4*†
Glucose 1.2 +− 0.1 1.3 +− 0.2 1.6 +− 0.1 1.5 +− 0.2
G-6-P 0.5 +− 0.04 2.6 +− 0.4* 0.7 +− 0.1 1.8 +− 0.1*†
G-1-P 0.01 +− 0.01 0.01 +− 0.01 0.03 +− 0.01 0.03 +− 0.01
F-6-P 0.04 +− 0.02 0.24 +− 0.05* 0.08 +− 0.02 0.23 +− 0.04*
Pyr 0.3 +− 0.02 1.1 +− 0.05* 0.3 +− 0.02 0.8 +− 0.07*†
Lac, muscle 5.3 +− 0.5 47.8 +− 1.1* 4.5 +− 0.3 26.3 +− 2.4*†
Lac, released 0.7 +− 0.2 4.6 +− 0.4* 1.9 +− 0.04 4.7 +− 0.5*
Muscle pH 7.0 +− 0.01 6.8 +− 0.01* 7.0 +− 0.01 6.9 +− 0.01*†
 Glycogen – 26.3 +− 0.9 – 13.6 +− 1.4*
Calculated glycogenolytic flux – 26.0 +− 0.9 – 13.7 +− 1.4*
*Significantly different from resting value.
†Significantly different from Con.
as those previously reported for rat muscle [36] as well as for
muscles immediately excised and frozen from a similar sized
rat [37]. This demonstrates that pre-incubation of muscles in
oxygenated Krebs–Ringer solution for 90 min with addition of
cyanide during the final 5 min of incubation had a minor influence
on muscle metabolites. However, when non-stimulated muscles
were incubated with cyanide at 30 ◦C for 10 min (n = 12), muscle
Lac increased by 7-fold [35.4 +− 1.7 mmol · kg− 1 dw (dry weight)]
and PCr decreased to 39% of initial level (40.0 +− 2.8 mmol · kg− 1
dw). In Con1/2 muscles ATP levels did not change during
the stimulation in either of the protocols, whereas ADP was
significantly increased and the ATP/ADP ratio was significantly
decreased after the stimulation in all protocols. However, a large
fraction of ADP and AMP is considered to be bound to proteins or
otherwise sequestered in the cell; thus the muscle concentration
of the metabolic active forms was estimated. Both [ADPfree] and
[AMPfree] were significantly increased after contractions, with a
2- and 4-fold higher concentration of [ADPfree] and [AMPfree]
respectively in Con compared with BTS muscles (Table 1). PCr
decreased by 73% in Con muscles, with a significantly less severe
decrease in BTS (48%) and Con1/2 (51%) muscles. The decrease
in PCr was paralleled by a similar increase in Cr. The relative ATP
provision from PCr and glycolysis to the total ATP utilization was
not significantly different between protocols (Table 3). Both Con
and BTS muscles showed an increase in GI (GI = glucose + G-6-
Table 3 ATP-turnover rates during stimulation
The values shown are means +− S.E.M. ATP-turnover data are given in mmol ATP, calculated
from the following formula: −PCr–(2 ×ATP–ADP) + 1.5 × (Lac +Pyr), where 
is the difference between stimulated and corresponding non-stimulated contralateral muscle;
n = 8 for both Con and BTS muscles.
Con BTS
ATP turnover (mmol ATP · kg− 1 dw) 147.7 +− 3.0 86.3 +− 2.5†
mmol ATP · kg− 1 dw s− 1 32.6 +− 2.4 18.4 +− 0.5†
mmol ATP · kg− 1 dw N · s− 1 46.5 +− 3.4 73.6 +− 2.7†
ATP derived from PCr (% of total) 51.4 +− 0.8 55.8 +− 2.6
ATP derived from glycolysis (% of total) 47.9 +− 0.7 43.2 +− 2.4
†Significantly different from Con.
P + G-1-P + F-6-P) after stimulation, with the most pronounced
being the 5–6-fold increases in G-6-P and F-6-P. Further, there
was a significant higher concentration of both total GI and G-6-P
after stimulation in Con than in BTS. Lac and pyruvate levels
increased significantly during both conditions, with the increase
being approx. 1.5-fold higher in Con than in BTS muscles. In line
with the increase in Lac, there was a larger decrease in muscle
glycogen levels in Con muscles (22%) than in BTS muscles
(12%), and no difference in resting levels. Using the values for
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Figure 2 Glycolytic and glycogenolytic rates
Stimulation of glycolytic (A) and glycogenolytic (B) rates in Con and BTS muscles with
supramaximal 60 Hz, 0.2 s pulses every 4 s. BTS muscles were incubated with the cross-bridge
cycle inhibitor BTS for 90 min prior to stimulation; n = 8 for Con and BTS muscles. Glycolytic
flux is calculated by (Lac+pyr)/2, and glycogenolytic flux is estimated from direct measures
of the difference in muscle glycogen content at rest and after stimulation. Rates are given per
stimulation period. †Significantly different from Con.
Lac and pyruvate, pHm was estimated after stimulation (Table 2).
The pHm decreased from the resting value after both treatments,
but reached a lower level in Con muscles than in BTS-treated
muscles.
ATP turnover
Using the metabolite values it was possible to calculate the
ATP utilization, ATP turnover and the rate of ATP utilization
during contraction (Table 3). ATP utilization in BTS was 58%
of that in Con and the turnover of ATP was significantly higher
(77%) in Con than in BTS muscles despite similar duration of
stimulation. In line with this, the ATP turnover per stimulation
time was significantly lower in BTS-treated muscles compared
with Con muscles (Table 3). When the ATP utilization was
related to the amount of isometric ‘work’, BTS muscles had a
significantly higher ATP utilization than Con muscles, due to the
inhibition of cross-bridge cycling, while maintaining normal SR
and sarcolemma/t-tubule ion-pumping (Table 3).
Glycolytic flux and glycolytic rates
There was a significantly lower glycolytic flux in BTS (12.5 +−
1.1 mmol glycosyl units · kg− 1 dw) muscles, averaging 54% of
that in Con muscles (23.6 +− 0.5 mmol glycosyl units · kg− 1 dw).
The effect of inhibiting cross-bridge cycling, while maintaining
normal Ca2+ transients, on the glycolytic rate is presented in
Figure 2(A). In BTS-treated muscle, the glycolytic rate was
approximately half of that in Con muscles.
Glycogenolytic flux and glycogenolytic rates
Glycogenolytic flux was estimated both from direct measures
of the decrease in muscle glycogen content after stimulation
(observed glycogenolysis), as well as from calculations based
Figure 3 Comparison of muscle PCr content with that of Lac
Values at rest (, Con;, BTS;H17009, 30◦C incubation for 10 min) and stimulated (, Con;,
BTS; , half work). The relationship between PCr and Lac is curvilinear and can be described
by the two-phase exponential decay equation: PCr = 59.6e− 0.035Lac + 54.8e− 0.035Lac (derived
from Con rest, Con stimulated and half work data); r2 = 0.95.
on the increase in Lac, pyruvate and GI (see the Calculations
subsection). There was good agreement between observed and
calculated glycogenolytic flux (Table 2). Glycogenolytic flux was
almost 2-fold higher in Con than in BTS-treated muscles. Despite
differences in glycogenolytic flux, there were no differences
between groups, in relation to the relative contribution of Lac,
pyruvate and GI in the calculated glycogenolytic flux, accounting
on average for 88, 1 and 11% of the glycosyl units respectively.
The glycogenolytic rate was on average 2-fold lower in BTS-
treated muscles compared with Con (Figure 2B).
PCr versus Lac levels
In a previous study, it was reported that there was a strong
logarithmic correlation between human muscle Lac accumulation
and PCr levels [21]. We wanted to test if this correlation would
also fit with BTS-treated muscles, having an approx. 2-fold
lower energy turnover while having the same Ca2+ transients
as Con muscles. The curvilinear relationship between PCr and
Lac derived from Con rest, Con stimulated and Con1/2 muscles
can be described by the two-phase exponential decay equation:
PCr = 59.6e− 0.035Lac + 54.8e− 0.035Lac (Figure 3). Even in our data,
using rat muscle, there is a strong relation between PCr and Lac
(r2 = 0.95), with the BTS-treated muscles fitting well with the
correlation. In line with this, the calculated contribution of PCr to
the total energy turnover was not significantly different between
conditions (Table 3). This demonstrates that treatment with BTS
does not affect the relation between PCr and Lac. If the hypothesis
that Ca2+ is an important trigger of glycolysis is correct, one
would expect that the relative ATP provision by glycolysis
would increase in BTS-treated muscles. PCr and Lac levels fitted
well with the correlation when the aerobic ATP formation was
inhibited by cyanide in quiescent muscle, i.e. increased rate of
anaerobic ATP formation (PCr utilization and glycolysis) without
increasing intracellular Ca2+. This observation supports the idea
that glycolysis is controlled by energy status and argues against
the hypothesis that Ca2+ is an important trigger of glycolysis.
Relative ATP utilization by cross-bridge cycling
A second purpose of the study was to determine the relative
ATP utilization by cross-bridge cycling during intermittent static
contractions. The relationship between isometric ‘work’ and ATP
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Figure 4 Relation between force–time integral and ATP utilization
The linear relationship between ATP utilization and the force-time integral (isometric ‘work’)
with 95 % confidence interval. The relation is best fitted by the following equation:
ATP utilization = 58.7 + 25.0 × force–time integral (R2 = 0.86). The intercept denotes
non-contractile energy utilization and was 59 (43–74) mmol ATP, and total energy utilization
was on average 146 mmol ATP · kg− 1 dm. Thus, under our conditions of intermittent static
contractions for 90 s, non-contractile energy utilization on average accounted for 40 %
(29–51 %) and the cross-bridge cycling corresponds to 60 % (49–71 %) of the total energy
utilization.
utilization in Con and BTS-treated muscles is shown in Figure 4.
Extrapolating the line defining the relationship to zero isometric
‘work’ gives an estimate of the ATP utilization by processes other
than cross-bridge cycling. Energy utilization by Con muscles
averaged 146 mmol ATP · kg− 1 dw (Table 3) and the intercept,
i.e. non-contractile energy utilization, was 59 mmol ATP · kg− 1
dw, with a 95% confidence interval of 43–74. Thus, under
our conditions of intermittent static contractions, non-contractile
energy utilization on average accounted for 40% (29–51%) and
the cross-bridge cycling corresponds to 60% (49–71%) of the
total energy utilization.
DISCUSSION
The major observation of the present study is that the rates of
glycogenolysis and glycolysis in contracting muscle are reduced
when energy turnover is reduced, despite maintenance of the
same normal Ca2+ transients as during contractions. The relative
glycolytic rate during prolonged cyanide treatment was also
independent of Ca2+ transients. This demonstrates that glycolytic
flux is controlled by factors related to energy state, but not by
Ca2+ directly. A second observation is that, using the cross-bridge
cycle inhibitor BTS, estimates of the ATP turnover demonstrate
that the cross-bridge cycling accounts for approx. 60% of the
total energy turnover by the skeletal muscle during intermittent
static contractions.
Regulation of glycolytic and glycogenolytic rates
Our findings are consistent with previous studies showing a close
relation between the rate of glycolysis and energy turnover [6].
By using BTS we were able to construct an experimental model
where changes in energy turnover were disconnected from parallel
changes in Ca2+ transients, i.e. reduced the energy turnover but
maintained Ca2+ transients. Several lines of observation from the
present study demonstrate that the glycolytic rate is controlled by
factors other than a direct effect of Ca2+ on the flux controlling
enzymes. First, the glycolytic rate in the BTS-treated muscles was
only half of that in the Con muscles (Table 3). Since muscles
treated with BTS maintain normal Ca2+ transients but have
reduced ATP turnover, this strongly indicates that the glycolytic
rate is controlled by energy state and not by a direct effect
of Ca2+. Secondly, the relationship between PCr and Lac was
independent of BTS (Figure 3) and the relative contribution of PCr
and glycolysis to the energy turnover was not different between
conditions (Table 3). If Ca2+ is the key factor in the control of
glycolytic rate, one would expect that Lac concentration in BTS
muscles would be higher than that observed, resulting in a higher
relative glycolytic ATP production versus Con and a rightward
shift of the relation shown in Figure 3. Thirdly, using prolonged
cyanide treatment of quiescent muscle, intracellular Ca2+ levels
remain low, while energy supply is covered by anaerobic ATP
formation. With this experimental approach the relation between
PCr and Lac was not changed. If Ca2+ is an important trigger of
glycolysis, one would, due to the absence of Ca2+ transients in
resting muscle, expect that the relation would change towards a
lower Lac and a higher PCr utilization. On the basis of our results,
we conclude that the glycolytic rate is controlled by factors related
to energy state but not by Ca2+ directly.
Furthermore, the theoretical base for Ca2+ being the trigger
of increased glycolysis is weak. Although the activation of
phosphorylase b kinase by Ca2+ and the contraction-induced trans-
formation of GPb into the more active GPa are well established,
there is no clearcut relation between the fraction of GP in the
form of GPa and glycogenolytic rate. First, GPa levels are already
high in resting muscle (approx. 10% of total GP) despite a low
rate of glycogenolysis [38]. Secondly, GPa increases transiently
at the onset of contraction, but is reverted back to the basal level
during sustained contraction despite high rates of glycogenolysis
[38]. Thirdly, when GP is almost totally converted into GPa by
adrenaline administration, the glycolytic rate only increases to
a minor extent, and is maintained below that during intensive
exercise [39]. It can be concluded that if Ca2+ is the main trigger
of glycogenolysis and glycolysis, this must occur through a
mechanism different from conversion of GPb into GPa. In line
with this contention, Crowther et al. [40] showed that hexose
phosphate levels remained high when exercise and glycolytic
flux ceased and they concluded that glycolysis was controlled
independently of glycogenolysis. As an alternative to activation
of GP by Ca2+ they suggested that glycolytic rate was directly
influenced by Ca2+ through Ca2+-initiated phosphorylation of
glycolytic enzymes and/or via Ca2+-mediated binding of these
enzymes to the cytoskeleton. The findings in the present study give
no support for such a mechanism but, on the contrary, demonstrate
that glycolytic flux is not controlled by Ca2+ directly. However,
the possibility that Ca2+ has a permissive role and that there is
a ‘dual-control’ model [41] to achieve high rates of glycolysis
cannot be excluded.
An important assumption for the above conclusion is that
skeletal-muscle intracellular Ca2+ transients ([Ca2+]i), are the
same during the various conditions, i.e. not affected by BTS and/or
contractions. BTS has been identified as a highly specific inhibitor
of myosin II ATPase that does not interfere with [Ca2+]i, which
has consistently been shown by direct measures of [Ca2+]i in
rabbit psoas muscle [15], mouse toe muscle [17,31], and as
in the present study, rat fast-twitch muscle [42]. Further there
is no effect of BTS on muscle excitability [19,36] or SR Ca2+
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pump ATP utilization [20]. Although tetanic [Ca2+]i is relatively
stable in isolated fibres, stimulated for several minutes using
a similar protocol as in present study (350 ms every 2.5–4 s;
[43]), it is conceivable that [Ca2+]i is decreased at fatigue during
the 90 s stimulation in Con. Importantly, this would strengthen
our proposition that the glycolytic rate is controlled by other
factors than by a direct effect of Ca2+ on the flux controlling
enzymes. Thus BTS muscles not developing fatigue, i.e. no
decrease in [Ca2+]i, have a lower glycolytic rate compared with
Con muscles with a conceivably decreased [Ca2+]i, while still
having a substantially higher glycolytic rate.
The present study demonstrates that the rates of glycolysis and
glycogenolysis are more closely related to energy state than to
intracellular Ca2+ transients. An elevated rate of ATP turnover
leads to increased muscle concentration of ADP, and due to
the presence of the adenylate kinase reaction, to even larger
increases in AMP. Calculated ADPfree increased approx. 7 times
after stimulation in Con, which was 2-fold higher than that in
stimulated BTS (Table 1). AMP is a more potent activator of GP
and PFK than ADP [2] and increases the affinity of GP for Pi and
of PFK for F-6-P. Calculated AMPfree increased approx. 50 times
after stimulation in Con, which was approx. 4 times higher than
that in BTS (Table 1). The concentration of AMP after stimulation
was 3.4 and 0.8 μM in Con and BTS respectively and is within the
range where GP is activated [6]. An increase in AMP is therefore
an attractive candidate for linking ATP turnover to increased rates
of glycolysis.
The glycolytic flux is immediately shut off when the contraction
terminates. This is the case even during ischaemic conditions
when the metabolic state is clamped with elevated levels of
ADPfree and AMPfree [4,21,40,41,44]. Studies using MRS, which
has a high temporal resolution, have confirmed the finding of an
immediate arrest of glycolytic rate during ischaemic conditions
[5]. The low rate of glycolysis in ischaemic quiescent muscle,
despite elevated ADP and AMP levels, has been taken as evidence
that glycolysis is not solely controlled by elevated metabolites
[4,40,41]. However, the concentrations of ADPfree and AMPfree
are calculated under the presumption that the creatine kinase
and adenylate kinase reactions are at equilibrium without cellular
concentration gradients. This is likely to be an oversimplified
model and it was suggested that rapid local changes occur in
the concentration of ADP and AMP in a contracting muscle
at the ATP-utilizing sites and that these are the triggers of
glycogenolysis and glycolysis [45]. The hypothesis of transient
changes in phosphate metabolites is supported by theoretical
modelling [46] and measurement in beating heart with high-
resolution MRS [47]. Supporting evidence also comes from the
observation that deamination of AMP to inosine monophosphate
and ammonia is a process that occurs in a fatigued muscle
during contraction but not during the subsequent ischaemic
recovery [37]. AMP deaminase is stimulated by increases in AMP
and the close link between AMP deamination and contraction
therefore gives indirect evidence of transient increases in AMP in
contracting muscle.
Cross-bridge ATP utilization
The present data show that the muscle cross-bridge cycling
accounts for 60% (49–71%) of skeletal-muscle total energy
turnover during intermittent static contractions under our condi-
tions. This is in line with the general acceptance that actomyosin
ATPase accounts for 50–80% of the ATP consumed during
muscle contractions of maximal or near maximal force [18,22–
30]. In the present study we have used BTS, which strongly
inhibits cross-bridge cycling without affecting Ca2+ handling
[15,17,18]. Using BTS, Walsh et al. [18] determined the relative
metabolic cost of cross-bridge cycling by estimating the fall
in intracellular pO2 in contracting isolated fibres from Xenopus
laevis muscle. During intermittent isometric contractions (250 ms
every 2–6 s for 100–200 s) at 20 ◦C, the relative ATP cost
used in cross-bridge cycling was 58% of overall ATP con-
sumption [18]. Recently, Barclay et al. [30] estimated cross-bridge
cycling accounts for slightly less than two-thirds of overall ATP
consumption, with no difference in estimates using the reduced
filament overlap or BTS. These estimates are very much in line
with the present data of 60% using a more direct approach to
determine metabolic cost in similar conditions in mammalian
muscle. All the above studies, including the present study, have
estimated the relative energy turnover by cross-bridge cycling, by
comparing the energy utilization with and without actomyosin
ATP turnover (i.e. stretch or BTS). This assumes that cross-
bridge cycling efficiency is unaltered during the contractile period.
However, muscle fibres increase efficiency with contraction time,
most pronounced in fast-twitch muscle [48], which is thought
to be a result of decreased actomyosin turnover. Thus the
estimated relative ATP consumption by cross-bridge cycling is
an average for the contractile period and, as a consequence,
underestimates ATP consumption for shorter stimulation periods
and overestimates for longer stimulation periods.
Recently, Zhang et al. [31] reported that cross-bridge cycling
accounts for only 18–25% of the consumed ATP during repeated
tetani for 100 s. The difference in the reported relative myosin
ATPase energy utilization may in part be explained by the methods
used to estimate the total ATP turnover. Both the present study
and Zhang et al. [31] have used cyanide to inhibit oxidative
phosphorylation, enabling the estimation of ATP utilization by
using conventional biochemical methods. There are, however,
some limitations and pitfalls with the technique. First, inhibiting
the mitochondrial oxidative phosphorylation at 30 ◦C may, in
contrast with that at 25 ◦C (used in the present study), lead
to perturbation of the resting muscle metabolite levels, i.e.
increased Lac and reduced PCr. This may lead to overestimation of
total ATP utilization in both Con and BTS and thus reduced rela-
tive ATP utilization by the cross-bridge cycling. However, with
this in mind, the differences between studies in temperature and
relative force during contraction, i.e. 25 ◦C and 83% Fmax (the
present study) versus 30 ◦C and 35% Fmax, may, as discussed by
Zhang et al. [31], be an important part of the explanation for the
observed differences in relative cross-bridge ATP utilization.
In conclusion, the present study demonstrates that reducing the
energy turnover during contractions in fast-twitch muscles, while
keeping normal Ca2+ transients, results in proportional decreases
in the glycogenolytic and glycolytic rates. This clearly reveals that
the rates of glycogenolysis and glycolysis are controlled by factors
related to energy turnover but not to Ca2+ directly. Furthermore,
estimates of the ATP turnover with and without inhibiting the
cross-bridge cycle reveal that the cross-bridge cycling accounts
for 60% of the total energy turnover by the skeletal muscle during
intermittent static contractions.
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